Cargando…
Fibroblast Growth Factor 23–Induced Hypophosphatemia in Acute Leukemia
Fibroblast growth factor 23 (FGF23)–induced hypophosphatemia is a rare paraneoplastic syndrome of phosphate wasting that, if unrecognized, may cause tumor-induced osteomalacia. It is classically associated with benign mesenchymal tumors but occasionally has been found in patients with other malignan...
Autores principales: | Reinert, Rachel B, Bixby, Dale, Koenig, Ronald J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912090/ https://www.ncbi.nlm.nih.gov/pubmed/29696242 http://dx.doi.org/10.1210/js.2018-00010 |
Ejemplares similares
-
An Unusually Prolonged Case of FGF23-mediated Hypophosphatemia Secondary to Ferric Carboxymaltose Use
por: Arora, Ipsa, et al.
Publicado: (2023) -
Tumor-induced hypophosphatemia
por: Mulani, M., et al.
Publicado: (2017) -
Current and Future Therapeutical Aspects of X-Linked Hypophosphatemia in Children With Special Attention to Klotho/Fibroblast Growth Factor 23 System
por: Bittmann, Stefan, et al.
Publicado: (2022) -
FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019) -
Acute Chest Pain in an Acute Complicated Pancreatitis with Severe Hypophosphatemia
por: Mahdi, Ahmad, et al.
Publicado: (2022)